Pharmaceutical Business review

ONCOlog Medical and C-RAD collaborate in radiotherapy

The two Swedish companies, ONCOlog Medical and C-RAD, offer technical solutions that quickly and exactly position patients and thereafter monitor the positioning during treatment. The aim of their strategic collaboration is to minimize the need for CT/MR-simulation before radiotherapy, as well as for individual fixation equipment. The collaboration facilitates new and efficient solutions that combine ONCOlog Medical’s PatLog Load and SteroLog with C-RAD’s Sentinel.

Hans Dahlin, CEO of ONCOlog Medical, said: “The companies’ complementing products for patient positioning ensures safer and more efficient radiation therapy, something that is high on the agenda at radiation clinics all over the world.”